Merck Taps Google DeepMind Spinout Isomorphic Labs to Design Cancer Drug Candidates, With No Human Testing Yet
Merck and Google DeepMind spinout Isomorphic Labs will use AI to design small-molecule cancer drug candidates, but the research remains untested and far from human trials.
Medical Daily ·